Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D T Vistica

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
Cancer Research|February 1, 1986
Arabinofuranosyl-5-azacytosine: antitumor and cytotoxic propertiesM Dalal, J Plowman, T R Breitman, et al.
The Journal of Urology|March 17, 2004
Sensitivity of renal cell carcinoma to aminoflavone: role of CYP1A1A I Loaiza-Pérez, S Kenney, J Boswell, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 1, 1987
The disposition and metabolism of 2',3'-dideoxycytidine, an in vitro inhibitor of human T-lymphotrophic virus type III infectivity, in mice and monkeysJ A Kelley, C L Litterst, J S Roth, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 1, 1996
Biological and biochemical anti-human immunodeficiency virus activity of UC 38, a new non-nucleoside reverse transcriptase inhibitorJ B McMahon, R W Buckheit, R J Gulakowski, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
Cancer Research|February 1, 1986
Arabinofuranosyl-5-azacytosine: antitumor and cytotoxic propertiesM Dalal, J Plowman, T R Breitman, et al.
The Journal of Urology|March 17, 2004
Sensitivity of renal cell carcinoma to aminoflavone: role of CYP1A1A I Loaiza-Pérez, S Kenney, J Boswell, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 1, 1987
The disposition and metabolism of 2',3'-dideoxycytidine, an in vitro inhibitor of human T-lymphotrophic virus type III infectivity, in mice and monkeysJ A Kelley, C L Litterst, J S Roth, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 1, 1996
Biological and biochemical anti-human immunodeficiency virus activity of UC 38, a new non-nucleoside reverse transcriptase inhibitorJ B McMahon, R W Buckheit, R J Gulakowski, et al.
Pageof 4